Jonathan Cotliar
Chief Medical Officer at Science 37 Holdings, Inc. (SNCE)
Jonathan Cotliar has filed 10 insider reports with the SEC since October 2021, as chief Medical Officer at Science 37 Holdings, Inc. (SNCE) and officer at Science 37 Holdings, Inc. (LSAQ). The latest filing, on March 12, 2024, reports sale back to the company and tender of shares in a change of control at Science 37 Holdings, Inc. (SNCE).
- Filings
- 10
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Jonathan Cotliar is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officer | 0 | Mar 12, 2024 | |||||
| Officersince October 2021 | 533,264 | Oct 13, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 12, 2024SNCECotliar Jonathan returned $73,968 worth of shares to the company (12,864 units at $5.75), closing all direct ownership in the companyForm 4Sale back to the companyTender of shares in a change of control
- Aug 12, 2023SNCESEC Form 4: Cotliar Jonathan converted options into 230,882 shares and covered exercise/tax liability with 79,839 shares, increasing direct ownership by 16% to 1,095,131 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Apr 28, 2023SNCESEC Form 4 filed by Cotliar JonathanForm 4Grant or awardSale back to the company
- Aug 12, 2022SNCESEC Form 4 filed by Cotliar JonathanForm 4Grant or award
- Apr 20, 2022SNCESEC Form 4: Cotliar Jonathan exercised 60,636 shares at a strike of $0.43, increasing direct ownership by 10% to 686,768 unitsForm 4Exercise or conversion of a derivative
- Dec 2, 2021SNCESEC Form 4: Cotliar Jonathan exercised 90,791 shares at a strike of $0.46, increasing direct ownership by 17% to 626,132 unitsForm 4Exercise or conversion of a derivative
- Jan 7, 2022SNCESEC Form 4 filed by Cotliar JonathanForm 4Grant or award
- Oct 7, 2021LSAQSEC Form 4 filed by Cotliar JonathanForm 4Grant or award
- Oct 6, 2021LSAQSEC Form 4: Cotliar Jonathan was granted 533,264 sharesForm 4Grant or award
- Oct 6, 2021LSAQJonathan Cotliar became an insiderForm 3New insider
Also sits on boards with
Officers and directors who share two or more companies with Jonathan Cotliar.
- Darcy Forman2 shared: SNCE, LSAQ
- Mike Zaranek2 shared: SNCE, LSAQ
- Christine A Pellizzari2 shared: SNCE, LSAQ
- David Coman2 shared: SNCE, LSAQ
- Steven Geffon2 shared: SNCE, LSAQ
- Adam Goulburn2 shared: SNCE, LSAQ
Compare Jonathan Cotliar with
- Jonathan Cotliar vs Robert C. Faulkner2 shared
- Jonathan Cotliar vs Darcy Forman2 shared
- Jonathan Cotliar vs Mike Zaranek2 shared
- Jonathan Cotliar vs Christine A Pellizzari2 shared
- Jonathan Cotliar vs Neil Tiwari2 shared
- Jonathan Cotliar vs Emily Rollins2 shared
Questions about Jonathan Cotliar
- What is Jonathan Cotliar's role at Science 37 Holdings, Inc.?
- Jonathan Cotliar reports to the SEC as chief Medical Officer at Science 37 Holdings, Inc. (SNCE), according to the latest filing on March 12, 2024. Jonathan Cotliar has also filed as officer at Science 37 Holdings, Inc. (LSAQ).
- How many shares does Jonathan Cotliar own?
- After the latest filing that states it, Jonathan Cotliar directly owned 533,264 shares of Science 37 Holdings, Inc. (LSAQ). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jonathan Cotliar bought or sold stock recently?
- No open-market purchases or sales by Jonathan Cotliar are on file. The filings report sale back to the company, tender of shares in a change of control, shares withheld for taxes or exercise price and exercise or conversion of a derivative.
- How do I get alerts when Jonathan Cotliar files?
- Follow Jonathan Cotliar on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Jonathan Cotliar (SEC CIK 0001886791). Totals count each trade once, skipping amendments whose original is on file, from Oct 9, 2021 on. View on SEC EDGAR